Ulf Klein

Ulf Klein is an accomplished leader in program and project management within the life sciences sector, currently serving as Head of PMO at Novocure since June 2022. Ulf has extensive experience in establishing and leading program management teams, developing strategic plans for medical affairs, and managing budgets to support portfolio decisions. Previous roles include Program Director at T-knife Therapeutics, Associate Director at Novartis Oncology where oversight of life-cycle teams for melanoma and lung cancer was key, and Associate Director for Organizational Transformation at Roche focusing on regulatory affairs. Ulf's educational background includes a PhD in Oncology and Cancer Biology from the Max-Planck Institute for Biochemistry and a Master's in Molecular Biology from the International Max-Planck Research School, showcasing a strong foundation in scientific research and strategy development in the healthcare domain.